Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Maceron Jul 24, 2019 10:24am
159 Views
Post# 29954308

RE:RE:RE:RE:RE:NEWS OUT Regarding US Sites

RE:RE:RE:RE:RE:NEWS OUT Regarding US Sites
enriquesuave wrote: Glad that they are putting all their efforts to move this PH2 as fast as possible.  As soon as FDA gives the OK, they should have the sites up and running enrolling and treating patients. They are talking rapid enrolment.  Within 9 -12 months we can most possibly enroll and treat 100-120 patients.  Trial ends 12 months after that. So company already is finalizing about 15 sites and TMO they hired will find last 4-6 sets to make a total of 20.   


Having 10-15 US sites will repidly increase enrollement. Bigger population = more patients to draw from + US based for profit system leads to hiring TMO's. Recruitment will be much faster. News like this should be turning heads but appears to have only stopped the whinning temporarily. Give it 24 hours and the manics will be at it again.
Macer 

Bullboard Posts